 |
[Alpha Biz=(Chicago) Reporter Kim Jisun] Domestic and foreign biopharmaceutical companies and wholesalers (pharmaceutical distribution companies) were found to have colluded in vaccine purchase bids, and were fined by the government.
The Fair Trade Commission (FTC) announced on the 20th that it would impose a penalty of 40.9 billion won on 32 pharmaceutical bio companies and wholesalers, including GlaxoSmithKline (GSK) and Yuhan Corporation, for engaging in unfair joint activities in relation to vaccine purchase bids.
As for vaccine manufacturers, a total of 32 vaccine-related businesses, including one global pharmaceutical company, GSK, Kwangdong Pharmaceutical, GC Biopharma, Boryeong Biopharma, SK Discovery, Yuhan Corporation, and Korea Vaccine Sales, 6 vaccine distributors and 25 pharmaceutical wholesalers, total 32 vaccine-related businesses. It was confirmed that in the bidding for 170 vaccines ordered by the Public Procurement Service from February 2019 to October 2019, the public procurement service set a prospective winning bidder in advance, recruited a bridesmaid, and then shared the price to be bid.
The vaccines they colluded with are all vaccines subject to the National Immunization Project (NIP), which is conducted with government budget, and totals 24 items.
According to the Fair Trade Commission, a prospective successful bidder submits a bid close to 100% of the base price (the price reviewed by the Public Procurement Service by referring to the market price and the contract price of the previous year, which bidders recognize as the upper limit price) in order to win the bid at the highest possible price, and the bridesmaids bid a few more than this. It was done in a way with a high percentage of bids.
Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)
